C

Chengdu Bright Eye Hospital Co Ltd
SZSE:301239

Watchlist Manager
Chengdu Bright Eye Hospital Co Ltd
SZSE:301239
Watchlist
Price: 47.05 CNY -3.53% Market Closed
Market Cap: 7B CNY
Have any thoughts about
Chengdu Bright Eye Hospital Co Ltd?
Write Note

Chengdu Bright Eye Hospital Co Ltd
Cash Paid for Dividends

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Chengdu Bright Eye Hospital Co Ltd
Cash Paid for Dividends Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash Paid for Dividends CAGR 3Y CAGR 5Y CAGR 10Y
C
Chengdu Bright Eye Hospital Co Ltd
SZSE:301239
Cash Paid for Dividends
-ÂĄ27.6m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
A
Aier Eye Hospital Group Co Ltd
SZSE:300015
Cash Paid for Dividends
-ÂĄ1.5B
CAGR 3-Years
-31%
CAGR 5-Years
-23%
CAGR 10-Years
-36%
Hengkang Medical Group Co Ltd
SZSE:002219
Cash Paid for Dividends
-ÂĄ124.7m
CAGR 3-Years
-48%
CAGR 5-Years
19%
CAGR 10-Years
-7%
X
XiAn International Medical Investment Co Ltd
SZSE:000516
Cash Paid for Dividends
-ÂĄ208.7m
CAGR 3-Years
2%
CAGR 5-Years
1%
CAGR 10-Years
-8%
H
Huaxia Eye Hospital Group Co Ltd
SZSE:301267
Cash Paid for Dividends
-ÂĄ157.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Sanbo Hospital Management Group Ltd
SZSE:301293
Cash Paid for Dividends
-ÂĄ554.1k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Chengdu Bright Eye Hospital Co Ltd
Glance View

Market Cap
7B CNY
Industry
Health Care

Chengdu Bright Eye Hospital Co Ltd. emerged as a beacon in the healthcare sector, nestled in the bustling city of Chengdu, China. The company carved its niche by focusing on a clear vision—literally and figuratively—through specializing in ophthalmic services. This focus on eye health is not only crucial in a densely populated region but also timely, as urban lifestyles contribute to rising eye health issues. With a commitment to offering comprehensive eye care, the hospital provides a range of services from basic eye examinations and common procedures like cataract surgeries, to advanced treatments involving laser technologies. This broad spectrum of services addresses the varied needs of patients, ensuring a continuous flow of clients from consultations to complex surgical interventions. The hospital operates in a competitive market but distinguishes itself by leveraging modern technology and an emphasis on patient-centric care. Its financial model is built around both volume and specialization, attracting patients through quality and trust. Revenue flows from direct payments for services rendered and strategic alliances with insurance companies that subsidize eye care treatments. Additionally, the hospital invests in community outreach and education, raising awareness about eye health and driving traffic to its facilities. Through a combination of strategic location, a diversified service portfolio, and a reputation for medical excellence, Chengdu Bright Eye Hospital not only captures a significant share of the regional eye care market but also sets a precedent for service-driven profitability in the healthcare sector.

Intrinsic Value
79 CNY
Undervaluation 40%
Intrinsic Value
Price
C

See Also

What is Chengdu Bright Eye Hospital Co Ltd's Cash Paid for Dividends?
Cash Paid for Dividends
-27.6m CNY

Based on the financial report for Dec 31, 2023, Chengdu Bright Eye Hospital Co Ltd's Cash Paid for Dividends amounts to -27.6m CNY.

What is Chengdu Bright Eye Hospital Co Ltd's Cash Paid for Dividends growth rate?
Cash Paid for Dividends CAGR 1Y
-206%

Over the last year, the Cash Paid for Dividends growth was -206%.

Back to Top